William Aird/X
May 5, 2026, 13:58
Hb vs Hct: Who’s in charge? – William Aird
William Aird, Professor of Medicine at Harvard Medical School, shared a post on X:
”Hb vs Hct: Who’s in charge?
Anemia?
Think Hb. Polycythemia?
Think Hct. At equipoise?
Dealer’s choice. (I lean Hb; call me an optimist)
Because O₂ delivery is a tradeoff: carrying capacity (Hb) vs flow (Hct).”
Other posts featuring William Aird on Hemostasis Today.
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
-
Jun 26, 2026, 05:55Shinya Goto: How Newton’s Laws Shape Platelet Function
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis
-
Jun 26, 2026, 05:26Maxime Dely: Strengthening Skills in Plasma and Red Cell Exchange
-
Jun 26, 2026, 05:26Andreas Calatzis: Hidden Differences in Anti-Xa Testing